Back to results
US 6,440,719 B1Granted
Method and reagent for inhibiting herpes simplex virus replication
AssigneeRibozyme Pharmaceuticals, Inc.
InventorKenneth G. Draper
Life of this patent
Estimating the term…
Abstract
An enzymatic RNA molecule which specifically cleaves a herpes simplex virus mRNA molecule.
Claims11
An enzymatic RNA molecule which cleaves RNA encoded by a herpes simplex virus (HSV) in a gene selected from ICP4, and UL5.
A method for treating a cell infected with latent HSV comprising the step of contacting an enzymatic RNA molecule which is active to specifically cleave RNA encoded by a herpes simplex virus (HSV) in a gene selected from ICP4 and UL5 with said infected cell.
Dependencies are inferred from the claim text.